Yadav Udit, Mangla Ankit
Department of Medicine, Division of Hematology and Oncology, John H Stroger, Jr Hospital of Cook County, Chicago, IL, USA.
Department of Hematology and Oncology, Case Western University School of Medicine, Cleveland, OH, USA.
Ecancermedicalscience. 2020 Jun 15;14:1056. doi: 10.3332/ecancer.2020.1056. eCollection 2020.
A primary cardiac angiosarcoma is a rare type of soft-tissue sarcoma with a high mortality rate. This report describes a young woman who presented with chest pain and worsening shortness of breath over the course of a year. She was diagnosed with and treated for latent tuberculosis and autoimmune pericarditis over the last year, however, her condition kept worsening. Further workup revealed a large pericardial and right atrial mass associated with multiple lung nodules. The biopsy from the lung mass showed angiosarcoma, and she was diagnosed with primary metastatic angiosarcoma of the pericardium. She was treated with doxorubicin and Ifosfamide (AIM-75 regimen), which led to a partial response. However, soon after completion of six cycles, the tumour progressed rapidly, leading to cardio-respiratory failure. In this report, we will discuss the clinical challenges and treatment options (surgical and medical) that are available for treating patients with angiosarcoma of the heart.
原发性心脏血管肉瘤是一种罕见的软组织肉瘤,死亡率很高。本报告描述了一名年轻女性,她在一年的时间里出现胸痛和呼吸急促加重的症状。去年她被诊断为潜伏性肺结核和自身免疫性心包炎并接受了治疗,然而,她的病情持续恶化。进一步检查发现一个大的心包和右心房肿块,伴有多个肺结节。肺肿块活检显示为血管肉瘤,她被诊断为心包原发性转移性血管肉瘤。她接受了阿霉素和异环磷酰胺(AIM - 75方案)治疗,产生了部分缓解。然而,在六个周期治疗完成后不久,肿瘤迅速进展,导致心肺衰竭。在本报告中,我们将讨论治疗心脏血管肉瘤患者时可采用的临床挑战和治疗选择(手术和药物治疗)。